bulkactives ghk cu GHK-CU 100 mg (10 vials) GHK-Cu – Peptides Collective

Composition: Sterile Water + 0.9% Benzyl Alcohol

[PMC free article: PMC3671347] [PubMed: 23761782] 51

Refrigerate at 28 C the moment reconstitution completes

Regulatory status (as of April 2026) Retatrutide is not FDA approved and not EMA approved as of April 2026

FDA's stated reasons: Immunogenicity risk Could trigger immune reactions Impurities Compounded versions may be contaminated Lack of characterization Don't fully understand the molecules No human safety data Haven't been properly tested Reported adverse events Some have documented side effects The DOJ Prosecution: $1.79 Million Forfeiture In a landmark case, the Department of Justice prosecuted Tailor Made Compounding LLC for distributing unapproved peptides including BPC-157